Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 158
Selected: 0
NCT IDTitle
NCT01376401Bendamustine, Bortezomib (Velcade ®) and Prednisone (BVP) in Patients Newly Diagnosed Multiple Myeloma
NCT02063139Knemometry Study to Compare the Systemic Safety of Flutiform pMDI, Fluticasone pMDI and Beclometasone Autohaler in Paediatric Subjects Aged 5 to Less Than 12 Years.
NCT02090972The Impact of Opioids in Fractures - a Case Control Study
NCT01099722Assessment of the Efficacy and Safety of FlutiForm® pMDI 125/5 µg (2 Puffs Bid) Versus Symbicort® Turbohaler® 200/6 µg (2 Puffs Bid) in Adolescent and Adult Subjects With Moderate to Severe Persistent, Reversible Asthma
NCT00742495Pharmacokinetic Study of Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin's Lymphoma.
NCT01983137A Non-interventional, Observational Study for Targinact® Treatment in Patients With Severe Pain.
NCT00769522FCR or BR in Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia
NCT01643759Norspan Transdermal Patches Study in Osteoarthritis Patients
NCT03967327A Study to Evaluate Buprenorphine Transdermal Patch in Chinese Subjects With Moderate to Severe Chronic Cancer Pain
NCT07093203Rezafungin Peritoneal Diffusion for Intra-abdominal Candidiasis
NCT03975010Buprenorphine Transdermal Patches Pharmacokinetic Study
NCT05432375Study of Tinostamustine for Adjuvant Treatment of Glioblastoma
NCT00951457Bendamustine Combined With Alemtuzumab in Pretreated Chronic Lymphocytic Leukemia (CLL)
NCT02126709The Efficacy and Safety of 3% Povidone-Iodine in Acne Therapy
NCT03687125Tinostamustine Conditioning and Autologous Stem Cell
NCT04124510Efficacy and Safety of Flutiform K-haler in Patients With Uncontrolled Asthma Following Mid-dose ICS/LABA DPI Therapy
NCT03349333A Single Arm Study Evaluating the Efficacy and Safety of Pralatrexate in Subjects With Relapsed or Refractory PTCL
NCT02811315Flutiform in Treatment of Patients With Asthma in Daily Clinical Practice.
NCT01701076Bendamustine, Lenalidomide (Revlimid®) and Dexamethasone (BRd) as 2nd-line Therapy for Patients With Relapsed or Refractory Multiple Myeloma
NCT01079117Morphine Slow-release Capsules in Substitution Therapy
NCT02256202Quality Assurance of Electronic Data Capturing (EDC) in Pain Treatment
NCT03398330OTR Tablet 40 mg Fed-state Bioequivalence Study
NCT02732886Betafoam Diabetes Mellitus Foot Study
NCT01961271Evaluation Of Efficacy And Safety Of Norspan In Moderate To Severe Pain Due To Osteoarthritis, Rheumatoid Arthritis, Joint/Muscle Pain
NCT03176199A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer Pain
NCT01170052Bendamustine and Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Non-Hodgkin's Lymphoma (NHL)
NCT00399178A Randomised Open Controlled Parallel Group Study Comparing Norspan and Tramadol
NCT02693769A Study to Compare Fluticasone /Formoterol Breath Actuated Inhaler (BAI) and Ultibro in Subjects With Fixed Airflow Obstruction and Elevated Eosinophils
NCT01476774NORSPAN Transdermal Patches Phase III Study In Non-Cancer Pain
NCT01710917A Non-interventional, Observational Study for Quality of Life (Overall Health Assessment) in Patients With Chronic Severe Pain During Targinact® Treatment
NCT00944697A Study to Demonstrate the Analgesic Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Addition to Pregabalin Compared to Pregabalin Alone in Opioid-naïve Subjects Treated With Pregabalin Suffering From Moderate to Severe Pain Due to Diabetic Polyneuropathy
NCT01885182Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain
NCT00963534Lenalidomide, Bendamustine and Rituximab as First-line Therapy for Patients Over 65 Years With Mantle Cell Lymphoma.
NCT03789630Continuous Monitoring of Physiology and Self-reported Pain Score Amongst Post-surgical Knee Patients
NCT01304134Oxycodone Hydrochloride Injection in the Postoperative Pain Relieving Treatment
NCT00412100Oxycodone-naloxone Prolonged Release Tablets in Relieving Opioid-related Constipation
NCT00412152Oxycodone-naloxone in Relieving Opioid-related Constipation
NCT03176121Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer Pain
NCT00995800Study to Assess Airway Inflammation Effects of FlutiForm® pMDI Low and High Dose in Adults With Mild to Moderate Asthma
NCT01423032Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL)
NCT02660541Burn Wound Management of Betafoam® and Allevyn® Ag
NCT01957046A Single-arm, Study to Assess the Effect and Tolerability of Standardised Laxative Therapy (SLT) for the Reversal of Opioid-induced Constipation (OIC).
NCT00646165Trial of Forodesine in Patients With Relapsed B-cell Chronic Lymphocytic Leukemia
NCT01821040A Study Assessing the Efficacy and Safety of Lodotra® Compared to Prednisone IR in Subjects Suffering From PMR
NCT02431624An Assessment of Buprenorphine Transdermal Delivery System (BTDS) Patch Adhesion
NCT01225861Prospective Study on the Use of Transdermal Analgesic Buprenorphine Patches for Chronic Pain in the UK
NCT01971632A Randomised, Double Blind, Placebo and Active Controlled, Double Dummy,Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Nonmalignant Pain
NCT01675531A Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)
NCT01449123Mannitol Challenge Test in Adult Asthma Patients With Fixed Dose Combinations
NCT02446561A Study of Whether 3 New Oral Formulations of a Strong Pain Killer Release the Same Amount of Drug Into the Body as the Marketed Medication